 | |
Subscribe to our Email List
| |
| |
06 Jan 2010
Application for admission of new Ordinary Shares |
Further to the announcement on 18 December 2009, regarding the issue of 17,705,384 new Ordinary Shares the Company is pleased to announce that it has now issued a further 5,560,300 ordinary shares of 0.1 pence each in the Company ("New Ordinary Shares"). The New Ordinary Shares have been issued pursuant to the Placing announced on 8 December and as a result of the Company having since received clearance from HM Revenue & Customs as to eligibility of the New Ordinary Shares under the Venture Capital Trust Scheme ("VCT") and Enterprise Investment Scheme ("EIS").
Application has been made for the New Ordinary Shares to be admitted to trading on AIM and it is expected that this will take place on 08 January 2010 ("Admission"). Following Admission, the total issued share capital of the Company will be 238,747,039 Ordinary Shares.
Defined terms in this announcement should be taken to have the same meaning as set out in the circular which was posted to shareholders on 8 December 2009.
For further information:
Verona Pharma Plc
Professor Clive Page, Chairman
Tel: 07971 504 931
Evolution Securities Limited (Nominated Adviser)
Tim Worlledge / Tim Redfern / Esther Lee
Tel : 020 7071 4300
Bishopsgate Communications Ltd.
Suzanne Johnson-Walsh/ Gemma O'Hara
Tel: 0207 562 3350 |
|
| |
| | You can view the Next News Releases item: Thu Jan 14, 2010, New Year Progress Report on Verona Pharma plc
You can view the Previous News Releases item: Thu Dec 24, 2009, Result of General Meeting
You can return to the main News Releases page, or press the Back button on your browser.
|
| | |
